Determination of butyrylcholinesterase activity based on thiamine luminescence modulated by MnO2 nanosheets

Talanta ◽  
2021 ◽  
Vol 224 ◽  
pp. 121831
Author(s):  
Zhengyi Qu ◽  
Tian Yu ◽  
Yuzhong Liu ◽  
Lihua Bi
2021 ◽  
Author(s):  
Xinfa Cai ◽  
Meijuan Liang ◽  
Fei Ma ◽  
Sherif Ramzy Mohamed ◽  
Amira Abdel Goda ◽  
...  

A direct competitive nanozyme-linked immunosorbent assay (dcNLISA) based on MnO2 nanosheets (MnO2 NSs) as a nanozyme label was developed for the highly sensitive determination of fumonisin B1 (FB1). The MnO2...


2020 ◽  
Vol 5 (2) ◽  
pp. 86-94
Author(s):  
Himayat Ullah ◽  
Khair Zaman ◽  
Muhammad Ismail

BenzilideneBenzylamine the derivative of Schiff bases contain azomethine group already used widely for industrial purposes and have wide range of biological activities. Benzilidene Benzylamine were synthesized by microwave irradiation reacting different aromatic and aniline purified pure crystal, 85% yield obtained reaction monitor by TLC. The Anticholinesterase activity utilized spectrophotometric Ellman assay for determination of butyrylcholinesterase and acetylcholinesterase. The synthesis compound 1 – 6 showed a wide range of inhibitory activity the compound 3((E)-N-(4-fluorobenzylidene)aniline) at 1000µg/mL, 71.62±0.74 percent inhibitory acetylcholinesterase potential while compound 6 ((E)-4 ((phenylimino)methyl) benzaldehyde) at 500 and 1000 µg/mL at IC50 show 71.68±0.22, 77.84±0.32 percent inhibitory potential comparatively greater than standard Galanthamine at 62.5µg/mL, 74.10±0.90 at IC50. The butyrylcholinesterase activity of compound 6 ((E)-4 ((phenylimino)methyl)benzaldehyde) at 1000 µg/mL, show 75.83±1.07 percent inhibitory potential which is similar to standard compound at 62.5µg/mL concentration of 75.45±0.90 percent butyrylcholinesterase inhibitory activity.


2017 ◽  
Vol 12 (7) ◽  
pp. 1934578X1701200 ◽  
Author(s):  
Kazuya Murata ◽  
Yusuke Ishida ◽  
Arisa Nishio ◽  
Sayaka Nakagawa ◽  
Hirokazu Kawamoto ◽  
...  

In our research program for investigating anti-dementia agents from natural plant resources, we screened extracts from 15 spice samples. Among the plant extracts tested, ethyl acetate extract prepared from rhizome of Zingiber zerumbet showed potent activity. Activity-guided purification led to determination of afzelin and its acetylated compound as the active principles. Afzelin showed moderate inhibitory activity against acetylcholinesterase and may also be expected to possess anti-butyrylcholinesterase activity. This is the first report to reveal the anti-cholinesterase activities of ethyl acetate extract of Z. zerumbet and afzelin. Furthermore, Z. zerumbet may be a potential therapeutic agent for the improvement of dementia, especially Alzheimer's disease.


2019 ◽  
Vol 186 (12) ◽  
Author(s):  
Xian-En Zhao ◽  
Ya-Nan Zuo ◽  
Xiaoqing Qu ◽  
Jing Sun ◽  
Lingyuan Liu ◽  
...  

2015 ◽  
Vol 69 (8) ◽  
Author(s):  
Miroslav Pohanka

AbstractTwo cholinesterases: acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), are known. The enzymes are important in the body and alteration of their activity has significant use in the diagnosis of poisoning, liver function, etc. Currently available methods for the determination of cholinesterases have some major drawbacks including various interferences and the inability to be used for decreasing the enzyme activity in the presence of reversible inhibitors due to sample dilution; hence, a method for dilution free assay of cholinesterases is desired. Here, microplates were modified with indoxylacetate (100 μL of 10 mmol L


Sign in / Sign up

Export Citation Format

Share Document